Exact Mass: 424.0480388

Exact Mass Matches: 424.0480388

Found 104 metabolites which its exact mass value is equals to given mass value 424.0480388, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Cefuroxime

(6R,7R)-3-[(Carbamoyloxy)methyl]-7-{[(2Z)-2-furan-2-yl-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C16H16N4O8S (424.0688816)


Cefuroxime is only found in individuals that have used or taken this drug. It is a broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, gonorrhea, and haemophilus. [PubChem]Cefuroxime, like the penicillins, is a beta-lactam antibiotic. By binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, it inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins; it is possible that cefuroxime interferes with an autolysin inhibitor. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DC - Second-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AA - Antibiotics D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

   

BL V

3-(Acetyloxy)-6,11,12-trihydroxy-5-(4-hydroxyphenyl)-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(9),2(7),3,5,10,12-hexaen-4-yl acetic acid

C22H16O9 (424.0794286)


BL V is found in mushrooms. BL V is a constituent of the kurukawa mushroom (Boletopsis leucomelas) (edibility not reported).

   

(1S,2R,3R,4S)-1-{(1S)-2-[(2R,3S,4S)-3,4-Dihydroxy-2-(hydroxymethyl)tetrahydrothiophenium-1-yl]-1-hydroxyethyl}-2,3,4,5-tetrahydroxypentyl sulfate

(1S,2R,3R,4S)-1-{(1S)-2-[(2R,3S,4S)-3,4-dihydroxy-2-(hydroxymethyl)tetrahydrothiophenium-1-yl]-1-hydroxyethyl}-2,3,4,5-tetrahydroxypentyl sulphuric acid

C12H24O12S2 (424.0709144)


   

5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,3-[[(aminocarbonyl)oxy]methyl]-7-[[(2Z)-2-furanyl(methoxyimino)acetyl]amino]-8-oxo-, (6R,7R)-

7-{[2-(furan-2-yl)-1-hydroxy-2-(methoxyimino)ethylidene]amino}-3-[(C-hydroxycarbonimidoyloxy)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

C16H16N4O8S (424.0688816)


   

7-Hydroxyethyl biscoumacetate

Ethyl 2-(4,7-dihydroxy-2-oxo-2H-chromen-3-yl)-2-(4-hydroxy-2-oxo-2H-chromen-3-yl)acetic acid

C22H16O9 (424.0794286)


D006401 - Hematologic Agents > D000925 - Anticoagulants > D015110 - 4-Hydroxycoumarins

   

Zibotentan

trans,trans-2(4-Methoxyphenyl)-4-(1-3-benzodiazol-5-yl)-1-(dibutylaminocarbonylmethyl)pyrrolidine-3-carboxylic acid

C19H16N6O4S (424.0953696)


Zibotentan is an orally available selective antagonist of the endothelin-A (ET-A) receptor with potential antineoplastic activity. Zibotentan binds selectively to the ET-A receptor, thereby inhibiting endothelin-mediated mechanisms that promote tumor cell proliferation. Zibotentan (ZD4054) is a potent, selective and orally active endothelin A (ETA) receptor antagonist with a Ki of 13 nM. Zibotentan has no inhibitory effect on ETB. Zibotentan has anticancer effects and can be used for castration-resistant prostate cancer (CRPC) research. Zibotentan. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=186497-07-4 (retrieved 2024-10-09) (CAS RN: 186497-07-4). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

   
   

2,3,4,4a,7,7a,9,10,11,11a,14,14a-Dodecahydro-4,11-dihydroxy-8H,13H-6a,13a-epidithio-1H,6H-pyrazino[1,2-a:4,5-a]diindole-1,6,8,13-tetrone

2,3,4,4a,7,7a,9,10,11,11a,14,14a-Dodecahydro-4,11-dihydroxy-8H,13H-6a,13a-epidithio-1H,6H-pyrazino[1,2-a:4,5-a]diindole-1,6,8,13-tetrone

C18H20N2O6S2 (424.076274)


   

Hypnum acid

3,5,7,4-Tetrahydroxyflavanone 3- (4-hydroxybenzoic acid)

C22H16O9 (424.0794286)


   
   
   
   

6-(3,4-Dihydroxyphenyl)-6a,12b-dihydro-3,10,11,12-tetrahydroxy-[2]benzopyrano[3,4-c]benzopyran-8(6H)-one

6-(3,4-Dihydroxyphenyl)-6a,12b-dihydro-3,10,11,12-tetrahydroxy-[2]benzopyrano[3,4-c]benzopyran-8(6H)-one

C22H16O9 (424.0794286)


   

Quercetin 7,3,4-trimethyl ether 3-sulfate

2- (3,4-dimethoxyphenyl) -5-hydroxy-7-methoxy-3- (sulfooxy) -4H-1-Benzopyran-4-one

C18H16O10S (424.04641560000005)


   

Mikanin 3-O-sulfate

3,5-Dihydroxy-4,6,7-trimethoxyflavone 3-O-sulfate

C18H16O10S (424.04641560000005)


   
   
   
   

(2R,3S,10S)-7,8,9,13-tetrahydroxy-2-(3,4-dihydroxyphenyl)-2,3-trans-3,4-cis-2,3,10-trihydrobenzopyrano<3,4-c>-2-benzopyran-1-one|(2R,3S,10S)-7,8,9,13-tetrahydroxy-2-(3,4-dihydroxyphenyl)-2,3-trans-3,4-cis-2,3,10-trihydrobenzopyrano[3,4-c]-2-benzopyran-1-one|(2R,3S,4S)-6-(3,4-Dihydroxyphenyl)-6alpha,12b-dihydro-3,10,11,12-tetrahydroxy[2]benzopyrano[3,4-c][1]benzopyran-8(6H)-one|(6R,6aS,12bR)-3,10,11,12-tetrahydroxy-6-(3,4-dihydroxyphenyl)-6a,12b-dihydro[1]benzopyrano[3,4-c][2]benzopyran-8(6H)-one

(2R,3S,10S)-7,8,9,13-tetrahydroxy-2-(3,4-dihydroxyphenyl)-2,3-trans-3,4-cis-2,3,10-trihydrobenzopyrano<3,4-c>-2-benzopyran-1-one|(2R,3S,10S)-7,8,9,13-tetrahydroxy-2-(3,4-dihydroxyphenyl)-2,3-trans-3,4-cis-2,3,10-trihydrobenzopyrano[3,4-c]-2-benzopyran-1-one|(2R,3S,4S)-6-(3,4-Dihydroxyphenyl)-6alpha,12b-dihydro-3,10,11,12-tetrahydroxy[2]benzopyrano[3,4-c][1]benzopyran-8(6H)-one|(6R,6aS,12bR)-3,10,11,12-tetrahydroxy-6-(3,4-dihydroxyphenyl)-6a,12b-dihydro[1]benzopyrano[3,4-c][2]benzopyran-8(6H)-one

C22H16O9 (424.0794286)


   

2-Hydroxy-3-chlordiospyrin|3-Chloro, 2-hydroxy-Diospyrin

2-Hydroxy-3-chlordiospyrin|3-Chloro, 2-hydroxy-Diospyrin

C22H13ClO7 (424.03497780000004)


   

6-Methoxycomaparvin 5-methyl ether sulphate

6-Methoxycomaparvin 5-methyl ether sulphate

C19H20O9S (424.082799)


   
   
   

(2R,3S)-trans-8-(2-carbonyl-4,5-dihydroxy)-phenyl-7,7-lactonecatechin|catechin lactone A

(2R,3S)-trans-8-(2-carbonyl-4,5-dihydroxy)-phenyl-7,7-lactonecatechin|catechin lactone A

C22H16O9 (424.0794286)


   
   

7-hydroxy-ethyl-biscoumacetate

7-hydroxy-ethyl-biscoumacetate

C22H16O9 (424.0794286)


   

2-[2-(acetylamino)-4-amino-5-methoxyphenyl]-5-amino-7-bromo-4-chloro-2H-benzotriazole

2-[2-(acetylamino)-4-amino-5-methoxyphenyl]-5-amino-7-bromo-4-chloro-2H-benzotriazole

C15H14BrClN6O2 (424.0050074)


   

(2S, 3R)-9-(5,6-dihydroxy-2-hydroxymethyl-2,3-dihydrobenzofuran-3-yloxy)-6H-dibenzopyran-6-one|(2S, 3R)-9-(5,6-dihydroxy-2-hydroxymethyl-2,3-dihydrobenzo[b]furan-3-yloxy)-6H-dibenzo[b,d]pyran-6-one|5-Hyddroxy-9-[(2,3-Dihydro-6-hydroxy-2-(hydroxymethyl)-3-benzofuranyl)oxy]3,10-dihydroxy-6H-dibenzo[b,d]pyran-6-one

(2S, 3R)-9-(5,6-dihydroxy-2-hydroxymethyl-2,3-dihydrobenzofuran-3-yloxy)-6H-dibenzopyran-6-one|(2S, 3R)-9-(5,6-dihydroxy-2-hydroxymethyl-2,3-dihydrobenzo[b]furan-3-yloxy)-6H-dibenzo[b,d]pyran-6-one|5-Hyddroxy-9-[(2,3-Dihydro-6-hydroxy-2-(hydroxymethyl)-3-benzofuranyl)oxy]3,10-dihydroxy-6H-dibenzo[b,d]pyran-6-one

C22H16O9 (424.0794286)


   
   
   

cefuroxime

5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,3-[[(aminocarbonyl)oxy]methyl]-7-[[2-furanyl(methoxyimino)acetyl]amino]-8-oxo-, [6R-[6a,7b(E)]]-

C16H16N4O8S (424.0688816)


J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DC - Second-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AA - Antibiotics D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain. C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

   

Cys Cys Cys Pro

(2S)-1-[(2R)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid

C14H24N4O5S3 (424.0908774)


   

Cys Cys Pro Cys

(2R)-2-{[(2S)-1-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanoic acid

C14H24N4O5S3 (424.0908774)


   

Cys Pro Cys Cys

(2R)-2-[(2R)-2-{[(2S)-1-[(2R)-2-amino-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C14H24N4O5S3 (424.0908774)


   

Pro Cys Cys Cys

(2R)-2-[(2R)-2-[(2R)-2-[(2S)-pyrrolidin-2-ylformamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C14H24N4O5S3 (424.0908774)


   

Thiamin diphosphate

2-[3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl]ethyl phosphono hydrogen phosphate

C12H18N4O7P2S (424.03714180000003)


   

HPF

(2-[6-(4-hydroxy)phenoxy-3H-xanthene-3-on-9-yl]benzoic acid

C26H16O6 (424.0946836)


   

BL V

3-(acetyloxy)-6,11,12-trihydroxy-5-(4-hydroxyphenyl)-8-oxatricyclo[7.4.0.0^{2,7}]trideca-1(13),2,4,6,9,11-hexaen-4-yl acetate

C22H16O9 (424.0794286)


   

cyclohexyltriphenylphosphonium bromide

cyclohexyltriphenylphosphonium bromide

C24H26BrP (424.09553860000005)


   

Decamethyl 1,9 dichloropentasiloxane

Decamethyl 1,9 dichloropentasiloxane

C10H30Cl2O4Si5 (424.036744)


   

4-(5-Bromo-thiophene-2-sulfonyl)-2-methyl-piperazine-1-carboxylic acid tert-butyl ester

4-(5-Bromo-thiophene-2-sulfonyl)-2-methyl-piperazine-1-carboxylic acid tert-butyl ester

C14H21BrN2O4S2 (424.01260460000003)


   
   

2-BROMO-9,9-DI-P-TOLYL-9H-FLUORENE

2-BROMO-9,9-DI-P-TOLYL-9H-FLUORENE

C27H21Br (424.0826526)


   

2-[2-(Methylthio)pyrimidin-4-yl]-1-[1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridin-5-yl]ethanone

2-[2-(Methylthio)pyrimidin-4-yl]-1-[1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridin-5-yl]ethanone

C20H16N4O3S2 (424.06637859999995)


   

3-(2-(2,4-DIFLUOROPHENOXY)-6-OXO-6H-PYRIDO[1,2-B]PYRIDAZIN-5-YL)-4-METHOXYBENZOIC ACID

3-(2-(2,4-DIFLUOROPHENOXY)-6-OXO-6H-PYRIDO[1,2-B]PYRIDAZIN-5-YL)-4-METHOXYBENZOIC ACID

C22H14F2N2O5 (424.0870738)


   
   

1H-Pyrrolo[2,3-b]pyridine-1-carboxylic acid, 3-iodo-5-(1-Methyl-1H-pyrazol-4-yl)-, 1,1-dimethylethyl ester

1H-Pyrrolo[2,3-b]pyridine-1-carboxylic acid, 3-iodo-5-(1-Methyl-1H-pyrazol-4-yl)-, 1,1-dimethylethyl ester

C16H17IN4O2 (424.0396212)


   

alpha-[2,3-dihydro-3-(tetrahydro-2,4,6-trioxo-5(2H)-pyrimidinylidene)-1H-isoindol-1-ylidene]-1,4-dihydro-4-oxoquinazoline-2-acetonitrile

alpha-[2,3-dihydro-3-(tetrahydro-2,4,6-trioxo-5(2H)-pyrimidinylidene)-1H-isoindol-1-ylidene]-1,4-dihydro-4-oxoquinazoline-2-acetonitrile

C22H12N6O4 (424.09199920000003)


   

URANYL ACETATE DIHYDRATE

URANYL ACETATE DIHYDRATE

C4H10O8U (424.088352)


   

2,3-BIS(4-NITROPHENYL)-5-PHENYLTETRAZOLIUM CHLORIDE

2,3-BIS(4-NITROPHENYL)-5-PHENYLTETRAZOLIUM CHLORIDE

C19H13ClN6O4 (424.06867680000005)


   
   

1,8-Bis(phenylthio)anthracene-9,10-dione

1,8-Bis(phenylthio)anthracene-9,10-dione

C26H16O2S2 (424.05916759999997)


   

Posaconazole Impurity 25

Posaconazole Impurity 25

C16H19F2IO3 (424.0346958)


   

1,1,2-Triphenyl-2-(4-bromomethylphenyl)ethylene

1,1,2-Triphenyl-2-(4-bromomethylphenyl)ethylene

C27H21Br (424.0826526)


   
   

2-Naphthalenecarboxylic acid, 3-hydroxy-4-(4-methyl-3-sulfophenyl)azo-, calcium salt

2-Naphthalenecarboxylic acid, 3-hydroxy-4-(4-methyl-3-sulfophenyl)azo-, calcium salt

C18H12CaN2O6S (424.0041962)


   

(3S,4R)-METHYL 3-(4-CHLOROBENZOYL)-6-(4-CHLOROPHENYL)-3,4,5-TRIHYDROXY-6-OXOHEXANOATE

(3S,4R)-METHYL 3-(4-CHLOROBENZOYL)-6-(4-CHLOROPHENYL)-3,4,5-TRIHYDROXY-6-OXOHEXANOATE

C20H18Cl2O6 (424.0480388)


   

rac-Ethylenebis(4,5,6,7-tetrahydro-1-indenyl)]zirconium dichloride

rac-Ethylenebis(4,5,6,7-tetrahydro-1-indenyl)]zirconium dichloride

C20H24Cl2Zr (424.0302044)


   

rac-ethylenebis(4,5,6,7-tetrahydro-1-indenyl)zirconium dichloride

rac-ethylenebis(4,5,6,7-tetrahydro-1-indenyl)zirconium dichloride

C20H24Cl2Zr-- (424.0302044)


   

1,2-Diacetoxy-4,7,8-trihydroxy-3-(4-hydroxyphenyl)dibenzofuran

1,2-Diacetoxy-4,7,8-trihydroxy-3-(4-hydroxyphenyl)dibenzofuran

C22H16O9 (424.0794286)


   

ROS Probe, HPF

ROS Probe, HPF

C26H16O6 (424.0946836)


D004396 - Coloring Agents > D005456 - Fluorescent Dyes > D005452 - Fluoresceins

   

4,5-Dihydroxy-3-(phenyldiazenyl)naphthalene-2,7-disulfonic acid

4,5-Dihydroxy-3-(phenyldiazenyl)naphthalene-2,7-disulfonic acid

C16H12N2O8S2 (424.0035072)


   

2-(1,3-Benzodioxol-5-ylmethylthio)-5-(2-furanyl)-3-prop-2-enyl-4-thieno[2,3-d]pyrimidinone

2-(1,3-Benzodioxol-5-ylmethylthio)-5-(2-furanyl)-3-prop-2-enyl-4-thieno[2,3-d]pyrimidinone

C21H16N2O4S2 (424.0551456)


   

2-[(3-Hydroxy-2-methyl-5-phosphonooxymethyl-pyridin-4-ylmethyl)-imino]-5-phosphono-pent-3-enoic acid

2-[(3-Hydroxy-2-methyl-5-phosphonooxymethyl-pyridin-4-ylmethyl)-imino]-5-phosphono-pent-3-enoic acid

C13H18N2O10P2 (424.0436668)


   

Zibotentan

Zibotentan (ZD4054)

C19H16N6O4S (424.0953696)


C28313 - Endothelin Receptor Antagonist Zibotentan (ZD4054) is a potent, selective and orally active endothelin A (ETA) receptor antagonist with a Ki of 13 nM. Zibotentan has no inhibitory effect on ETB. Zibotentan has anticancer effects and can be used for castration-resistant prostate cancer (CRPC) research[1][2].

   

N-[3-(1,3-benzothiazol-2-yl)-4-chlorophenyl]-2,6-dimethoxybenzamide

N-[3-(1,3-benzothiazol-2-yl)-4-chlorophenyl]-2,6-dimethoxybenzamide

C22H17ClN2O3S (424.06483620000006)


   

(1S,2R,3R,4S)-1-{(1S)-2-[(2R,3S,4S)-3,4-Dihydroxy-2-(hydroxymethyl)tetrahydrothiophenium-1-yl]-1-hydroxyethyl}-2,3,4,5-tetrahydroxypentyl sulfate

(1S,2R,3R,4S)-1-{(1S)-2-[(2R,3S,4S)-3,4-dihydroxy-2-(hydroxymethyl)tetrahydrothiophenium-1-yl]-1-hydroxyethyl}-2,3,4,5-tetrahydroxypentyl sulphuric acid

C12H24O12S2 (424.0709144)


   

Adenosine-diphosphate

Adenosine-diphosphate

C10H12N5O10P2-3 (424.0059412)


COVID info from COVID-19 Disease Map, WikiPathways Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   
   
   
   

[(Z)-[2-(4-hydroxyphenyl)-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanylethylidene]amino] sulfate

[(Z)-[2-(4-hydroxyphenyl)-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanylethylidene]amino] sulfate

C14H18NO10S2- (424.03721079999997)


   

rostratin B

rostratin B

C18H20N2O6S2 (424.076274)


An organic disulfide isolated from the whole broth of the marine-derived fungus Exserohilum rostratum and has been shown to exhibit antineoplastic activity.

   

(2,6-Difluorophenyl)-[4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-1-piperazinyl]methanone

(2,6-Difluorophenyl)-[4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-1-piperazinyl]methanone

C19H18F2N2O5S (424.09044420000004)


   

1-(Benzenesulfonyl)-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)piperazine

1-(Benzenesulfonyl)-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)piperazine

C18H20N2O6S2 (424.076274)


   

N-(3,5-dichloro-2-pyridinyl)-2-[[1-(2-methoxyethyl)-2-benzimidazolyl]thio]propanamide

N-(3,5-dichloro-2-pyridinyl)-2-[[1-(2-methoxyethyl)-2-benzimidazolyl]thio]propanamide

C18H18Cl2N4O2S (424.0527468)


   

N-(3-chlorophenyl)-4-fluoro-3-(thiophen-2-ylmethylsulfamoyl)benzamide

N-(3-chlorophenyl)-4-fluoro-3-(thiophen-2-ylmethylsulfamoyl)benzamide

C18H14ClFN2O3S2 (424.0118376)


   

[4-(2,6-Difluorophenyl)sulfonyl-1-piperazinyl]-(2,3-dihydro-1,4-benzodioxin-6-yl)methanone

[4-(2,6-Difluorophenyl)sulfonyl-1-piperazinyl]-(2,3-dihydro-1,4-benzodioxin-6-yl)methanone

C19H18F2N2O5S (424.09044420000004)


   

1-(2-Furanylmethyl)-3-[[[4-(4-morpholinylsulfonyl)phenyl]-oxomethyl]amino]thiourea

1-(2-Furanylmethyl)-3-[[[4-(4-morpholinylsulfonyl)phenyl]-oxomethyl]amino]thiourea

C17H20N4O5S2 (424.087507)


   

5,12-Dihydroxanthommatin(1-)

5,12-Dihydroxanthommatin(1-)

C20H14N3O8- (424.0780864)


   

[4-[[[4-(4-fluorophenyl)-5-pyridin-4-yl-1H-imidazol-2-yl]thio]methyl]phenyl]-hydroxy-methylsulfonium

[4-[[[4-(4-fluorophenyl)-5-pyridin-4-yl-1H-imidazol-2-yl]thio]methyl]phenyl]-hydroxy-methylsulfonium

C22H19FN3OS2+ (424.0953516)


   

(6R,7S)-3-(carbamoyloxymethyl)-7-[[(2E)-2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

(6R,7S)-3-(carbamoyloxymethyl)-7-[[(2E)-2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C16H16N4O8S (424.0688816)


   

(5E)-3-(Furan-2-ylmethyl)-5-[[1-(4-methoxyphenyl)-2,5-dimethylpyrrol-3-yl]methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one

(5E)-3-(Furan-2-ylmethyl)-5-[[1-(4-methoxyphenyl)-2,5-dimethylpyrrol-3-yl]methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one

C22H20N2O3S2 (424.091529)


   

4-[[3-(3-Chloro-4-methylphenyl)-4-oxo-2-quinazolinyl]thio]-2-(1-iminoethyl)-3-oxobutanenitrile

4-[[3-(3-Chloro-4-methylphenyl)-4-oxo-2-quinazolinyl]thio]-2-(1-iminoethyl)-3-oxobutanenitrile

C21H17ClN4O2S (424.0760692)


   

2-(2-Oxo-9-sulooxy-8,9-dihydrouro[2,3-h]chromen-8-yl)propan-2-yl 3-methylbut-2-enoate

2-(2-Oxo-9-sulooxy-8,9-dihydrouro[2,3-h]chromen-8-yl)propan-2-yl 3-methylbut-2-enoate

C19H20O9S (424.082799)


   

ADP(3-)

ADP(3-)

C10H12N5O10P2 (424.0059412)


A nucleoside 5-diphosphate(3-) arising from deprotonation of all three diphosphate OH groups of adenosine 5-diphosphate (ADP); major species present at pH 7.3.

   

dGDP(3-)

dGDP(3-)

C10H12N5O10P2 (424.0059412)


A 2-deoxyribonucleoside 5-diphosphate obtained by deprotonation of the diphosphate OH groups of dGDP.

   

8-oxo-dADP(3-)

8-oxo-dADP(3-)

C10H12N5O10P2 (424.0059412)


An organophosphate oxoanion obtained by deprotonation of the diphosphate OH groups of 8-oxo-dADP.

   

thiamine(1+) diphosphate(1-)

thiamine(1+) diphosphate(1-)

C12H18N4O7P2S (424.03714180000003)


An ammonium betaine that is the conjugate base of thiamine(1+) diphosphate arising from the deprotonation of one of the hydroxy groups of the terminal phosphate group.

   

ML375

ML375

C23H15ClF2N2O2 (424.07900639999997)


ML375 (VU0483253) is a potent, highly selective, brain-penetrant and orally active M5 mAChR negative allosteric modulator (NAM) with IC50s of 300 nM and 790 nM for human and rat M5, respectively. ML375 is inactive at human and rat M1-M4[1].

   

NP-1815-PX (sodium)

NP-1815-PX (sodium)

C21H13N4NaO3S (424.0606028000001)


NP-1815-PX sodium is a potent and selective P2X4R antagonist. NP-1815-PX sodium has anti-inflammatory activity, and can relieve pain in chronic pain models. NP-1815-PX sodium also inhibits guinea pig tracheal/bronchial smooth muscle (TSM and BSM) contractions[1][2][3].

   

9-(3,4-dihydroxyphenyl)-5,15,16,17-tetrahydroxy-8,11-dioxatetracyclo[8.8.0.0²,⁷.0¹³,¹⁸]octadeca-2,4,6,13(18),14,16-hexaen-12-one

9-(3,4-dihydroxyphenyl)-5,15,16,17-tetrahydroxy-8,11-dioxatetracyclo[8.8.0.0²,⁷.0¹³,¹⁸]octadeca-2,4,6,13(18),14,16-hexaen-12-one

C22H16O9 (424.0794286)


   

4-(acetyloxy)-6,11,12-trihydroxy-5-(4-hydroxyphenyl)-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(9),2(7),3,5,10,12-hexaen-3-yl acetate

4-(acetyloxy)-6,11,12-trihydroxy-5-(4-hydroxyphenyl)-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(9),2(7),3,5,10,12-hexaen-3-yl acetate

C22H16O9 (424.0794286)


   

{3-[(1e)-2-(3,4-dihydroxyphenyl)ethenyl]-8,9-dihydroxy-1-oxo-6h-pyrano[4,3-c]isochromen-6-yl}acetic acid

{3-[(1e)-2-(3,4-dihydroxyphenyl)ethenyl]-8,9-dihydroxy-1-oxo-6h-pyrano[4,3-c]isochromen-6-yl}acetic acid

C22H16O9 (424.0794286)


   

5,8,15,18-tetrahydroxy-21,22-dithia-3,13-diazahexacyclo[9.9.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁴,¹⁹]docosa-6,16-diene-2,12-dione

5,8,15,18-tetrahydroxy-21,22-dithia-3,13-diazahexacyclo[9.9.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁴,¹⁹]docosa-6,16-diene-2,12-dione

C18H20N2O6S2 (424.076274)